ESR1 and breast cancer: Gallen Consensus classified breast cancer into five subtypes according to the biomarker expression (estrogen receptor [ER], progesterone receptor [PR], human epidermal growth factor receptor-2 [HER2], and Ki67) evaluated using immunohistochemistry (IHC) [3].